Yeonjung Jo

机构：University of Utah, Huntsman Cancer Institute · ORCID：0000-0002-1630-2957

发表论文 125 篇 · 总被引 688 次 · h-index 10

代表论文

• Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US (2025 · JAMA Network Open · 被引 12)
• Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy (2025 · Prostate Cancer and Prostatic Diseases · 被引 7)
• Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States (2026 · JAMA Network Open · 被引 5)
• First-Line Ipilimumab with Nivolumab versus Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors in Patients with Intermediate- or Poor-Risk Metastatic Clear Cell Renal Cell Carcinoma (2025 · Journal of Kidney Cancer and VHL · 被引 3)
• Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216 (2024 · European Urology Oncology · 被引 3)
• Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer (2024 · Clinical Lung Cancer · 被引 3)